LLY

1,021.22

-2.93%↓

JNJ

243.76

+0.38%↑

ABBV

227

-2.16%↓

NVS

165.91

+0.18%↑

MRK

120.8

-0.53%↓

LLY

1,021.22

-2.93%↓

JNJ

243.76

+0.38%↑

ABBV

227

-2.16%↓

NVS

165.91

+0.18%↑

MRK

120.8

-0.53%↓

LLY

1,021.22

-2.93%↓

JNJ

243.76

+0.38%↑

ABBV

227

-2.16%↓

NVS

165.91

+0.18%↑

MRK

120.8

-0.53%↓

LLY

1,021.22

-2.93%↓

JNJ

243.76

+0.38%↑

ABBV

227

-2.16%↓

NVS

165.91

+0.18%↑

MRK

120.8

-0.53%↓

LLY

1,021.22

-2.93%↓

JNJ

243.76

+0.38%↑

ABBV

227

-2.16%↓

NVS

165.91

+0.18%↑

MRK

120.8

-0.53%↓

Search

Inspire Medical Systems Inc

Ouvert

SecteurSoins de santé

61.96 0.41

Résumé

Variation du prix de l'action

24h

Actuel

Min

58.27

Max

61.95

Chiffres clés

By Trading Economics

Revenu

126M

136M

Ventes

45M

269M

P/E

Moyenne du Secteur

12.221

110.024

Marge bénéficiaire

50.577

Employés

1,333

EBITDA

28M

45M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+62.32% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-225M

1.7B

Ouverture précédente

61.55

Clôture précédente

61.96

Sentiment de l'Actualité

By Acuity

55%

45%

298 / 351 Classement par Healthcare

Inspire Medical Systems Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

17 févr. 2026, 23:44 UTC

Actions en Tendance

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

17 févr. 2026, 23:20 UTC

Résultats

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

17 févr. 2026, 22:57 UTC

Résultats

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

17 févr. 2026, 21:59 UTC

Résultats

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

17 févr. 2026, 23:54 UTC

Market Talk

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

17 févr. 2026, 23:54 UTC

Market Talk

Global Equities Roundup: Market Talk

17 févr. 2026, 23:54 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 févr. 2026, 23:45 UTC

Market Talk

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

17 févr. 2026, 23:19 UTC

Résultats

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 23:15 UTC

Résultats

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 22:58 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

17 févr. 2026, 22:58 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

17 févr. 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

17 févr. 2026, 22:50 UTC

Acquisitions, Fusions, Rachats

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

17 févr. 2026, 22:44 UTC

Résultats

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

17 févr. 2026, 22:42 UTC

Résultats

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

17 févr. 2026, 22:36 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

17 févr. 2026, 22:36 UTC

Résultats

Santos Final Dividend 10.3 U.S. Cents/Security

17 févr. 2026, 22:36 UTC

Résultats

Santos FY Underlying Profit US$898 Million, Down 25%

17 févr. 2026, 22:35 UTC

Résultats

Santos FY Revenue US$4.94 Billion, Down 8%

17 févr. 2026, 22:35 UTC

Résultats

Correct: Santos FY Net Profit US$818 Million, Down 33%

17 févr. 2026, 22:35 UTC

Acquisitions, Fusions, Rachats

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

17 févr. 2026, 22:34 UTC

Résultats

Santos FY Net Profit US$818 Billion, Down 33%

17 févr. 2026, 22:02 UTC

Acquisitions, Fusions, Rachats

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

17 févr. 2026, 21:50 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

17 févr. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 févr. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 févr. 2026, 21:49 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

17 févr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

17 févr. 2026, 21:48 UTC

Acquisitions, Fusions, Rachats

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Comparaison

Variation de prix

Inspire Medical Systems Inc prévision

Objectif de Prix

By TipRanks

62.32% hausse

Prévisions sur 12 Mois

Moyen 97 USD  62.32%

Haut 175 USD

Bas 67 USD

Basé sur 18 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

18 ratings

6

Achat

12

Maintien

0

Vente

Sentiment

By Acuity

298 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Inspire Medical Systems Inc

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
help-icon Live chat